Konstantinos Votanopoulos to Organoids
This is a "connection" page, showing publications Konstantinos Votanopoulos has written about Organoids.
Connection Strength
2.367
-
Votanopoulos KI, Skardal A. ASO Author Reflections: Co-cultured Lymph Node and Tumor Organoids as a Platform for the Creation of Adaptive Immunity and Predict Response to Immunotherapy. Ann Surg Oncol. 2020 Jun; 27(6):1968-1969.
Score: 0.654
-
Votanopoulos KI, Forsythe S, Sivakumar H, Mazzocchi A, Aleman J, Miller L, Levine E, Triozzi P, Skardal A. Model of Patient-Specific Immune-Enhanced Organoids for Immunotherapy Screening: Feasibility Study. Ann Surg Oncol. 2020 Jun; 27(6):1956-1967.
Score: 0.643
-
Votanopoulos KI, Mazzocchi A, Sivakumar H, Forsythe S, Aleman J, Levine EA, Skardal A. Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study. Ann Surg Oncol. 2019 Jan; 26(1):139-147.
Score: 0.595
-
Forsythe SD, Moaven O, Votanopoulos KI. ASO Author Reflections: Patient-Derived Tumor Organoids-A Platform for a Precision Approach for Peritoneal Malignancies. Ann Surg Oncol. 2020 Dec; 27(13):4961-4962.
Score: 0.168
-
Forsythe SD, Sasikumar S, Moaven O, Sivakumar H, Shen P, Levine EA, Soker S, Skardal A, Votanopoulos KI. Personalized Identification of Optimal HIPEC Perfusion Protocol in Patient-Derived Tumor Organoid Platform. Ann Surg Oncol. 2020 Dec; 27(13):4950-4960.
Score: 0.167
-
Mazzocchi AR, Rajan SAP, Votanopoulos KI, Hall AR, Skardal A. In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening. Sci Rep. 2018 02 13; 8(1):2886.
Score: 0.141